Brainphonics is best understood as a clinical audiology tool built on neural speech tracking, a niche that sits apart from the broader EEG diagnostics space by targeting objective hearing assessment in non-cooperating populations. Its KU Leuven pedigree and clinical validation at UZ Leuven position it closer to translation than most grant-stage EEG startups, though commercialization remains early.